Skip Navigation


Nucleic Acids Research Advance Access originally published online on November 6, 2006
Nucleic Acids Research 2007 35(Database issue):D721-D726; doi:10.1093/nar/gkl811
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (1126K) Freely available
Right arrow Screen PDF (283K) Freely available
Right arrowOA All Versions of this Article:
35/suppl_1/D721    most recent
gkl811v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Higgins, M. E.
Right arrow Articles by Lash, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Higgins, M. E.
Right arrow Articles by Lash, A. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2007, Vol. 35, Database issue D721-D726
© 2006 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Articles

CancerGenes: a gene selection resource for cancer genome projects

Maureen E. Higgins, Martine Claremont, John E. Major, Chris Sander and Alex E. Lash*

Computational Biology Center Memorial Sloan-Kettering Cancer Center 1275 York Avenue, No. 460 New York, NY 10021, USA

*To whom correspondence should be addressed. Tel:+1 646 735 8087; Fax:+1 646 735 0021; Email: lash{at}cbio.mskcc.org

Received August 10, 2006. Revised October 2, 2006. Accepted October 3, 2006.

The genome sequence framework provided by the human genome project allows us to precisely map human genetic variations in order to study their association with disease and their direct effects on gene function. Since the description of tumor suppressor genes and oncogenes several decades ago, both germ-line variations and somatic mutations have been established to be important in cancer—in terms of risk, oncogenesis, prognosis and response to therapy. The Cancer Genome Atlas initiative proposed by the NIH is poised to elucidate the contribution of somatic mutations to cancer development and progression through the re-sequencing of a substantial fraction of the total collection of human genes—in hundreds of individual tumors and spanning several tumor types. We have developed the CancerGenes resource to simplify the process of gene selection and prioritization in large collaborative projects. CancerGenes combines gene lists annotated by experts with information from key public databases. Each gene is annotated with gene name(s), functional description, organism, chromosome number, location, Entrez Gene ID, GO terms, InterPro descriptions, gene structure, protein length, transcript count, and experimentally determined transcript control regions, as well as links to Entrez Gene, COSMIC, and iHOP gene pages and the UCSC and Ensembl genome browsers. The user-friendly interface provides for searching, sorting and intersection of gene lists. Users may view tabulated results through a web browser or may dynamically download them as a spreadsheet table. CancerGenes is available at http://cbio.mskcc.org/cancergenes.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
S. J. Furney, B. Calvo, P. Larranaga, J. A. Lozano, and N. Lopez-Bigas
Prioritization of candidate cancer genes--an aid to oncogenomic studies
Nucleic Acids Res., August 18, 2008; (2008) gkn482v1.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Shlien, U. Tabori, C. R. Marshall, M. Pienkowska, L. Feuk, A. Novokmet, S. Nanda, H. Druker, S. W. Scherer, and D. Malkin
Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome
PNAS, August 12, 2008; 105(32): 11264 - 11269.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
W. C. Cho
A future of cancer prevention and cures: highlights of the Centennial Meeting of the American Association for Cancer Research
Ann. Onc., February 1, 2008; 19(2): 205 - 211.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
A. L. Mayburd, I. Golovchikova, and J. L. Mulshine
Successful anti-cancer drug targets able to pass FDA review demonstrate the identifiable signature distinct from the signatures of random genes and initially proposed targets
Bioinformatics, February 1, 2008; 24(3): 389 - 395.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
G. Dawelbait, C. Winter, Y. Zhang, C. Pilarsky, R. Grutzmann, J.-C. Heinrich, and M. Schroeder
Structural templates predict novel protein interactions and targets from pancreas tumour gene expression data
Bioinformatics, July 1, 2007; 23(13): i115 - i124.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
R. M. Brena and J. F. Costello
Genome-epigenome interactions in cancer
Hum. Mol. Genet., April 15, 2007; 16(R1): R96 - R105.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.